NCT03505229View on ClinicalTrials.gov

Span-C-SBRT for Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

October 5, 2028

Study Completion Date

October 5, 2028

Conditions
High Risk Localised Pancreatic Cancer
Interventions
RADIATION

Stereotactic Body Radiotherapy (SBRT)

Stereotactic Body Radiotherapy (SBRT) 30-45 gray in 5 fractions over 2 weeks will be given to all eligible patients.

Trial Locations (1)

2065

RECRUITING

Royal North Shore Hospital, St Leonards

All Listed Sponsors
lead

Royal North Shore Hospital

OTHER